Intercept Pharmaceuticals (NASDAQ:ICPT) CMO David Shapiro sold 4,456 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $437.49, for a total transaction of $1,949,455.44. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) shares after opening at $352.36 moved to $360.10 on last trade day and at the end of the day closed at $322.32 . Company price to sales ratio in past twelve months was calculated as 3899.67 and price to cash ratio as 43.06. Intercept Pharmaceuticals Inc (NASDAQ:ICPT) showed a negative weekly performance of -26.57%.
Tetraphase Pharmaceuticals (NASDAQ:TTPH) has earned an average recommendation of “Buy” from the eight analysts that are covering the company, Analyst Ratings.Net reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) shares fell -7.19% in last trading session and ended the day on $10.58. TTPH return on equity ratio is recorded as -89.90% and its return on assets is -34.40%. Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH) yearly performance is 51.14%.
GW Pharmaceuticals PLC-ADR (NASDAQ:GWPH) has received a consensus recommendation of “Buy” from the eight brokerages that are currently covering the stock,AnalystRatingsNetwork.com reports. Seven research analysts have rated the stock with a buy rating, GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares moved down -6.84% in last trading session and was closed at $61.66 while trading in range of $61.51 – $67.20 – GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH ) year to date (YTD) performance is 48.44%.
Karyopharm Therapeutics, Inc. (Nasdaq:KPTI) 19.2% LOWER; filed to sell, from time to time, up to $115 million of its Common Stock on behalf of Selling Shareholders. The company will not receive proceeds from the Secondary Sales. Karyopharm Therapeutics Inc (NASDAQ:KPTI) weekly performance is -23.84%. On last trading day company shares ended up $32.01. Karyopharm Therapeutics Inc (NASDAQ:KPTI) distance from 50-day simple moving average (SMA50) is -10.05%. Analysts mean target price for the company is $48.25.